0.39
4.88%
-0.02
시간 외 거래:
.39
Glycomimetics Inc (GLYC) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
100.00%
-
|
0.01 | - | - | - |
Operating Expenses
|
15.77%
11.12
|
9.6008 | 9.8135 | 8.9299 | 10.94 |
Operating Income/Loss |
15.89%
-11.12
|
-9.5908 | -9.8135 | -8.9299 | -10.94 |
Income/Loss From Continuing Operations Before Tax |
18.26%
-10.74
|
-9.0786 | -9.2025 | -8.2589 | -10.36 |
Income Tax Expense/Benefit, Current |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
18.26%
-10.74
|
-9.0786 | -9.2025 | -8.2589 | -10.36 |
Net Income/Loss
|
18.26%
-10.74
|
-9.0786 | -9.2025 | -8.2589 | -10.36 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
18,292%
64.46
|
0.3505 | 64.35 | 64.28 | 60.35 |
Diluted Average Shares |
18,292%
64.46
|
0.3505 | 64.35 | 64.28 | 60.35 |
Basic Earnings Per Share |
21.43%
-0.17
|
-0.14 | -0.14 | -0.13 | -0.17 |
Diluted Earnings Per Share |
21.43%
-0.17
|
-0.14 | -0.14 | -0.13 | -0.17 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):